TY - JOUR
T1 - Between-center and between-country differences in outcome after aneurysmal subarachnoid hemorrhage in the subarachnoid hemorrhage international trialists (SAHIT) repository
AU - SAHIT collaboration
AU - Dijkland, Simone A.
AU - Jaja, Blessing N.R.
AU - van der Jagt, Mathieu
AU - Roozenbeek, Bob
AU - Vergouwen, Mervyn D.I.
AU - Suarez, Jose I.
AU - Torner, James C.
AU - Todd, Michael M.
AU - van den Bergh, Walter M.
AU - Saposnik, Gustavo
AU - Zumofen, Daniel W.
AU - Cusimano, Michael D.
AU - Mayer, Stephan A.
AU - Lo, Benjamin W.Y.
AU - Steyerberg, Ewout W.
AU - Dippel, Diederik W.J.
AU - Schweizer, Tom A.
AU - Loch Macdonald, R.
AU - Lingsma, Hester F.
AU - Noble, Adam
AU - de Oliveira Manoel, Airton Leonardo
AU - Raabe, Andreas
AU - Molyneux, Andrew
AU - Quinn, Audrey
AU - Schatlo, Bawarjan
AU - Matouk, Charles C.
AU - Fung, Christian
AU - Hänggi, Daniel
AU - Hasan, David
AU - Keller, Emanuela
AU - Gordon, Errol
AU - Rinkel, Gabriel J.E.
AU - Wong, George K.C.
AU - Fukuda, Hitoshi
AU - Torner, James C.
AU - Burkhardt, Jan Karl
AU - Fandino, Javier
AU - Pickard, John D.
AU - Spears, Julian
AU - Beck, Jürgen
AU - Schaller, Karl
AU - Sheth, Kevin N.
AU - Thorpe, Kevin E.
AU - Regli, Luca
AU - Seule, Martin
AU - Stienen, Martin N.
AU - Vergouwen, Mervyn D.I.
AU - Cusimano, Michael D.
AU - Reinert, Michael
AU - Roethlisberger, Michel
N1 - Publisher Copyright:
© AANS 2020, except where prohibited by US copyright law
PY - 2020/10
Y1 - 2020/10
N2 - OBJECTIVE Differences in clinical outcomes between centers and countries may reflect variation in patient characteristics, diagnostic and therapeutic policies, or quality of care. The purpose of this study was to investigate the presence and magnitude of between-center and between-country differences in outcome after aneurysmal subarachnoid hemorrhage (aSAH). METHODS The authors analyzed data from 5972 aSAH patients enrolled in randomized clinical trials of 3 different treatments from the Subarachnoid Hemorrhage International Trialists (SAHIT) repository, including data from 179 centers and 20 countries. They used random effects logistic regression adjusted for patient characteristics and timing of aneurysm treatment to estimate between-center and between-country differences in unfavorable outcome, defined as a Glasgow Outcome Scale score of 1-3 (severe disability, vegetative state, or death) or modified Rankin Scale score of 4-6 (moderately severe disability, severe disability, or death) at 3 months. Between-center and between-country differences were quantified with the median odds ratio (MOR), which can be interpreted as the ratio of odds of unfavorable outcome between a typical high-risk and a typical low-risk center or country. RESULTS The proportion of patients with unfavorable outcome was 27% (n = 1599). The authors found substantial between-center differences (MOR 1.26, 95% CI 1.16-1.52), which could not be explained by patient characteristics and timing of aneurysm treatment (adjusted MOR 1.21, 95% CI 1.11-1.44). They observed no between-country differences (adjusted MOR 1.13, 95% CI 1.00-1.40). CONCLUSIONS Clinical outcomes after aSAH differ between centers. These differences could not be explained by patient characteristics or timing of aneurysm treatment. Further research is needed to confirm the presence of differences in outcome after aSAH between hospitals in more recent data and to investigate potential causes.
AB - OBJECTIVE Differences in clinical outcomes between centers and countries may reflect variation in patient characteristics, diagnostic and therapeutic policies, or quality of care. The purpose of this study was to investigate the presence and magnitude of between-center and between-country differences in outcome after aneurysmal subarachnoid hemorrhage (aSAH). METHODS The authors analyzed data from 5972 aSAH patients enrolled in randomized clinical trials of 3 different treatments from the Subarachnoid Hemorrhage International Trialists (SAHIT) repository, including data from 179 centers and 20 countries. They used random effects logistic regression adjusted for patient characteristics and timing of aneurysm treatment to estimate between-center and between-country differences in unfavorable outcome, defined as a Glasgow Outcome Scale score of 1-3 (severe disability, vegetative state, or death) or modified Rankin Scale score of 4-6 (moderately severe disability, severe disability, or death) at 3 months. Between-center and between-country differences were quantified with the median odds ratio (MOR), which can be interpreted as the ratio of odds of unfavorable outcome between a typical high-risk and a typical low-risk center or country. RESULTS The proportion of patients with unfavorable outcome was 27% (n = 1599). The authors found substantial between-center differences (MOR 1.26, 95% CI 1.16-1.52), which could not be explained by patient characteristics and timing of aneurysm treatment (adjusted MOR 1.21, 95% CI 1.11-1.44). They observed no between-country differences (adjusted MOR 1.13, 95% CI 1.00-1.40). CONCLUSIONS Clinical outcomes after aSAH differ between centers. These differences could not be explained by patient characteristics or timing of aneurysm treatment. Further research is needed to confirm the presence of differences in outcome after aSAH between hospitals in more recent data and to investigate potential causes.
KW - Aneurysmal subarachnoid hemorrhage
KW - Center effects
KW - Outcome
KW - Quality of care
KW - Vascular disorders
UR - http://www.scopus.com/inward/record.url?scp=85092452804&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092452804&partnerID=8YFLogxK
U2 - 10.3171/2019.5.JNS19483
DO - 10.3171/2019.5.JNS19483
M3 - Article
C2 - 31443072
AN - SCOPUS:85092452804
SN - 0022-3085
VL - 133
SP - 1132
EP - 1140
JO - Journal of neurosurgery
JF - Journal of neurosurgery
IS - 4
ER -